A spotlight on pathogenesis, interactions and novel therapeutic options in NAFLD
Volume: 16, Issue: 2, Pages: 80 - 82
Published: Dec 17, 2018
Abstract
In 2018, there have been substantial advances in our understanding of the risk factors for advanced liver disease in nonalcoholic fatty liver disease, including genetic variants and the gut microbiota. Promising results have also arisen from drugs targeting metabolic pathways involved in the progression of liver...
Paper Details
Title
A spotlight on pathogenesis, interactions and novel therapeutic options in NAFLD
Published Date
Dec 17, 2018
Volume
16
Issue
2
Pages
80 - 82
Citation AnalysisPro
You’ll need to upgrade your plan to Pro
Looking to understand the true influence of a researcher’s work across journals & affiliations?
- Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
- Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.
Notes
History